Recent Quotes (30 days)

You have no recent quotes
chg | %

Finance

Results 1 - 5 of about 5 for ARRY
Company Exchange Symbol Last price Quote change Market cap
Array Biopharma Inc NASDAQ ARRY 7.40 +0.07 (0.95%) 1.03B
... inhibitor for MM; ARRY-797 in Phase II clinical trials, indicated for p38 inhibitor for Lamin A/C-related dilated cardiomyopathy (LMNA-DCM); ARRY-502 in ...
ARRAY BIOPHARMA DL-,001 FRA AR2 6.72 +0.37 (5.84%)
Oncothyreon Inc (USA) NASDAQ ONTY 1.65 +0.04 (2.48%) 168.80M
Oncothyreon Inc. (Oncothyreon) is a clinical-stage biopharmaceutical company focused primarily on the development of therapeutic products for the treatment ...
Arryx, Inc. Private
Arryx is HOT. It makes the BioRyx 200 system, which uses a holographic laser steering device to hold, move, rotate, separate, and stretch microscopic ...
ONCOTHYREON INC. FRA 3O6 1.45 +0.04 (2.90%)